Assembly Biosciences
ASMB • NASDAQ
Assembly Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason A. Okazaki, with a market cap of $439.4M.
CEOJason A. Okazaki
Next Earnings
Upcoming earnings announcement for Assembly Biosciences
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.78
Revenue Estimate
$7.1M
Earnings History
Past 12 earnings reports for Assembly Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | $1.30Est: -$0.71 | +283.1% | $42.5MEst: $8.7M | +388.5% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.72Est: -$0.59 | -22.0% | $10.8MEst: $9.7M | +11.5% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$1.33Est: -$1.73 | +23.1% | $9.6MEst: $5.3M | +81.7% | 10-Q |
| May 8, 2025 | Q1 2025 | -$1.17Est: -$1.60 | +26.9% | $9.4MEst: $7.4M | +27.1% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$1.57Est: -$1.75 | +10.3% | $7.4MEst: $7.1M | +4.4% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$1.51Est: -$2.02 | +25.2% | $6.8MEst: $8.6M | -20.8% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$1.98Est: -$2.23 | +11.2% | $8.5MEst: $6.0M | +43.2% | 10-Q |
| May 8, 2024 | Q1 2024 | -$1.66Est: -$3.24 | +48.8% | $5.8M | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$1.74Est: -$2.88 | +39.6% | $7.2M | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$3.24Est: -$2.76 | -17.4% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$3.84Est: -$3.48 | -10.3% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$4.44Est: -$4.20 | -5.7% | - | — | — |